Urinary Bladder Neoplasms

"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the URINARY BLADDER.

Descriptor ID	D001749
MeSH Number(s)	C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
Concept/Terms	Urinary Bladder Neoplasms Urinary Bladder Neoplasms Neoplasm, Urinary Bladder Urinary Bladder Neoplasm Neoplasms, Bladder Bladder Neoplasms Bladder Neoplasm Neoplasm, Bladder Bladder Tumors Bladder Tumor Tumor, Bladder Tumors, Bladder Urinary Bladder Cancer Urinary Bladder Cancer Cancer, Urinary Bladder Malignant Tumor of Urinary Bladder Cancer of the Bladder Bladder Cancer Bladder Cancers Cancer, Bladder Cancer of Bladder

Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Urologic Neoplasms [C04.588.945.947]
Urinary Bladder Neoplasms [C04.588.945.947.960]
Male Urogenital Diseases [C12]
Urogenital Neoplasms [C12.758]
Urologic Neoplasms [C12.758.820]
Urinary Bladder Neoplasms [C12.758.820.968]
Urologic Diseases [C12.777]
Urinary Bladder Diseases [C12.777.829]
Urinary Bladder Neoplasms [C12.777.829.813]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Neoplasms [C13.351.937]
Urologic Neoplasms [C13.351.937.820]
Urinary Bladder Neoplasms [C13.351.937.820.945]
Urologic Diseases [C13.351.968]
Urinary Bladder Diseases [C13.351.968.829]
Urinary Bladder Neoplasms [C13.351.968.829.707]

Below are MeSH descriptors whose meaning is related to "Urinary Bladder Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.

Bar chart showing 75 publications over 25 distinct years, with a maximum of 6 publications in 2005 and 2007 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2001	1	0	1
2002	2	0	2
2003	2	0	2
2004	3	0	3
2005	5	1	6
2007	6	0	6
2008	5	1	6
2009	4	0	4
2010	3	0	3
2011	3	0	3
2012	3	1	4
2013	3	0	3
2014	2	0	2
2015	2	1	3
2016	2	0	2
2017	1	0	1
2018	3	0	3
2019	2	0	2
2020	2	0	2
2021	3	0	3
2022	1	0	1
2023	4	0	4
2024	4	1	5
2025	2	1	3

Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.

Clements MB, Pekala KR, Tin AL, Sjoberg DD, Beech B, Atkinson T, Herr H, Donat SM, Vickers AJ, Dalbagni G, Bochner BH. Prospective health-related quality of life in women undergoing radical cystectomy and urinary diversion. BJU Int. 2025 Oct; 136(4):728-737.

View in: PubMed
Lee D, Jeon KH, Jung J, Han K, Cho MH, Cho IY, Shin DW. Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study. Rheumatology (Oxford). 2025 Jun 01; 64(6):3458-3467.

View in: PubMed
Seiden B, Ajay D, Cheung F, Clements M, Pietzak E. Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer. Curr Urol Rep. 2025 Jan 06; 26(1):24.

View in: PubMed
Mittal K, Joshi M. Perioperative immunotherapy in urothelial carcinoma: AMBASSADOR charts the path forward. Med. 2024 Dec 13; 5(12):1449-1451.

View in: PubMed
Moody KA, Iofel SS, Clements MB. Health-Related Quality of Life Across the Spectrum of Bladder Cancer: A Current Review. Curr Urol Rep. 2024 Dec 11; 26(1):21.

View in: PubMed
Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 Dec; 42(34):4095-4102.

View in: PubMed
Khosla H, Bhatt S, Wang MJ, Gignac G, Mittal K, Patel J. Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. J Oncol Pharm Pract. 2024 Jul; 30(5):941-944.

View in: PubMed
Mittal K, Joshi M. FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape. Med. 2024 Mar 08; 5(3):176-178.

View in: PubMed
Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, Donat SM, Sjoberg DD, Tin AL, Coleman JA, Rapkin BD, Laudone VP, Bochner BH. Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial. Reply. J Urol. 2023 09; 210(3):408.

View in: PubMed
Santoni M, Myint ZW, B?ttner T, Takeshita H, Okada Y, Lam ET, Gilbert D, K?ronya Z, Tural D, Pichler R, Grande E, Crabb SJ, Kemp R, Massari F, Scagliarini S, Iacovelli R, Vau N, Basso U, Maruzzo M, Molina-Cerrillo J, Galli L, Bamias A, De Giorgi U, Zucali PA, Rizzo M, Seront E, Popovic L, Caffo O, Buti S, Kanesvaran R, Kopecky J, Kucharz J, Zeppellini A, Fiala O, Landmesser J, Ansari J, Giannatempo P, Rizzo A, Zabalza IO, Monteiro FSM, Battelli N, Calabr? F, Porta C. Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study. Cancer Immunol Immunother. 2023 Sep; 72(9):2961-2970.

View in: PubMed

People

Explore

Similar Concepts

Top Journals